ProMIS Neurosciences
Aerami
We are advancing a diverse pipeline of inhaled therapies for the treatment of severe respiratory and chronic diseases.
Alveo
Know Sooner, Act Faster
Angion
Angion is a late-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic diseases.
Berkeley Lights
Sift through thousands of cells at once and get deep profiling with more relevant phenotypic, genotypic and imaging information for each single cell, across a number of dimensions.
Nova Signal
AI mapping of brain blood flow
CytoDyn
CytoDyn believes in the future of precision medicine... more specificity, less side effects. Our target, the CCR5 receptor, has been implicated in multiple disease processes from HIV, GVHD, NASH, stroke recovery, multiple sclerosis, Parkinson's disease, to metastatic cancer. Leronlimab, our CCR5 antagonist, is a once a week, subcutaneous injection. One molecule with multiple opportunities. With precision comes the opportunity for improved safety, convenience, and enhanced efficacy for the patient.
Precise Bio
Precise Bio's platform technology comprises tissue engineering, biomaterials, cell technologies, bioengineering concepts and a 4D